The FDA has approved the first oral PCSK9 inhibitor, a daily pill that lowers LDL cholesterol by nearly 60%, offering an ...
Companies in Africa and India will make generic versions of the pill that could cost as little as $5 per person per year. But ...
July 24 (Reuters) - The U.S. Food and Drug Administration on Friday approved a nonprescription, fixed-dose pill that combines ...
The FDA approved Lipfendra, a new drug for adults with high LDL cholesterol, as the first PCSK9 inhibitor available as a once ...
Merck’s pill, called Lipfendra, is a PCSK9 inhibitor, which works in a different way from a statin to lower cholesterol.
The Food and Drug Administration has approved a new pill that's been proven to significantly reduce levels of "bad" cholesterol. Clinical trials showed that Lipfendra, manufacture ...
The drug from Merck was OK'd for patients with artery-clogging cholesterol that persists even after taking statins.
The Food and Drug Administration on Thursday approved Merck's Lipfendra, which some have hailed as a breakthrough in ...
Merck & Co. won US regulatory approval of a pill that rivals powerful injections for cutting dangerous cholesterol levels, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results